Guaifenesin/hydrocodone - Mission Pharmacal

Drug Profile

Guaifenesin/hydrocodone - Mission Pharmacal

Alternative Names: Flowtuss; FlowtussTM; Guaifenesin/hydrocodone bitartrate - Mission Pharmacal

Latest Information Update: 04 Jan 2016

Price : $50

At a glance

  • Originator Mission Pharmacal
  • Class Antitussives; Expectorants; Morphinans; Opioid analgesics; Opioid peptides; Propylene glycols; Small molecules
  • Mechanism of Action Opioid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Cough

Most Recent Events

  • 19 Nov 2015 Launched for Cough in USA (PO) before November 2015
  • 14 May 2015 Registered for Cough in USA (PO)
  • 29 Nov 2010 Preregistration for Cough in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top